Table 2 The imaging features of the patients
Features | MVI-(n = 43) | MVI + (n = 19) | p Value |
|---|---|---|---|
Non-enhancement | |||
Mosaic architecture | |||
Yes | 7 (16.3%) | 1 (5.3%) | 0.233 |
Intralesional fat | |||
Yes | 16 (37.2%) | 4 (21.1%) | 0.210 |
Intratumor hemorrhage | |||
Yes | 2 (4.7%) | 3 (15.8%) | 0.138 |
Iso/hyper-intense SI (T1WI) | |||
Yes | 13 (30.2%) | 3 (15.8%) | 0.231 |
T2-DW mismatch | |||
Yes | 1 (2.3%) | 3 (15.8%) | 0.047 |
Morphology (T2WI) | |||
Round shape | 20 (46.5%) | 10 (52.6%) | 0.250 |
Lobulated | 20 (46.5%) | 6 (31.6%) | |
Irregular shape | 3 (7.0%) | 3 (15.8%) | |
Enhancement without HBP | |||
AP hyper-enhancement | |||
Yes | 32 (74.4%) | 14 (73.7%) | 0.951 |
Washout | |||
No enhancement | 4 (9.3%) | 1 (5.3%) | 0.804 |
Enhance and without Washout | 7 (16.3%) | 4 (21.1%) | |
Enhance and washout | 32 (74.4%) | 14 (73.7)) | |
Rim enhancement | |||
Yes | 5 (11.6%) | 9 (47.4%) | 0.006 |
Capsule enhancement | |||
Enhance and complete | 16 (37.2%) | 5 (26.3%) | < 0.001 |
Enhance and Uncomplete | 23 (53.5%) | 2 (10.5%) | |
No enhance | 4 (9.3%) | 12 (63.2%) | |
AP halo signs | |||
Yes | 5 (11.6%) | 9 (47.4%) | 0.006 |
HBP | |||
HBP high uptake | |||
Yes | 17 (39.5%) | 2 (10.5%) | 0.022 |
HBP halo sign | |||
Yes | 4 (9.3%) | 8 (42.1%) | 0.013 |
HBP morphology | |||
Round shape | 29 (67.4%) | 4 (21.1%) | < 0.001 |
Lobulated | 11 (25.6%) | 5 (26.3%) | |
Irregular shape | 3 (7.0%) | 10 (52.7%) | |
HBP spicule sign | |||
Yes | 3 (7.0%) | 12 (63.2%) | < 0.001 |
HBP brush sign | |||
Yes | 4 (9.3%) | 8 (42.1%) | 0.003 |